JPT Launches Online Shop to Provide Access to its Innovative Peptide Based Catalog Products

Berlin, Germany, September 1, 2011. JPT Peptide Technologies GmbH (JPT) announces the launch of its new online ordering platform.  The web-based system ( provides accelerated access to a wide range of unique, off-the-shelf peptide products.

Hundreds of novel products ranging from RepliTopeTM (peptide microarrays for serological profiling) and PepMixTM (peptide pools for antigen-specific T-cell stimulation) to peptide collections for profiling various enzymes (kinases, proteases, phosphatases, acetyltransferases) and newly released peptides for Alzheimer's research can now easily be purchased.

More accessible than ever before is JPT's vast and fast-growing collection of catalog peptide microarrays and peptide pools related to hundreds of tumor associated antigens as well as pathogens such as HIV, CMV, HPV, EBV, BKV, RSV, HBV, tuberculosis, influenza, and many others.

"JPT has always been a leading choice for integrated peptide technologies. The addition of the new online shop brings JPT's innovative products closer and faster to the hands of the user than ever before," says Holger Wenschuh, JPT’s Managing Director.

With the launch of the online shop JPT continues its strategic mission to become an integrated peptide company offering innovative catalog products and tailored services as well as being a valued R&D partner for peptide discovery and optimization projects.

About JPT Peptide Technologies GmbH

JPT Peptide Technologies GmbH,
a wholly-owned subsidiary of BioNTech AG (Mainz, Germany),  is a DIN ISO 9001:2008 certified research and development partner and innovative service and tool provider for peptide related projects.  JPT’s key technologies SPOTTM – for ultra-high-throughput peptide synthesis and screening, PepStarTM – for high-content peptide microarrays, PepTrackTM - for flexible peptide library assembly, PepMixTM– for antigen specific T-cell stimulation using peptide pools, and SpikeTideTM– for protein biomarker quantification, accelerate research in areas such as immune monitoring, vaccine development, peptide biomarker discovery, peptide lead identification and optimization, enzyme profiling and proteomics.

For further information please contact:

JPT Peptide Technologies GmbH
Dr. Holger Wenschuh
Managing Director
Volmerstr. 5
12555 Berlin/Germany
Tel: +49 - 30 – 6392 5500
Fax: +49 - 30 - 6392 5501




Stay in touch and be the first to receive the latest news!